Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:          
Net income $ 380,305 $ 369,100 $ 726,701   $ 765,044
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     187,122   31,893
Loss (gains) on unrealized foreign exchange and other     7,344   4,790
Stock-based compensation expense     53,733   31,833
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:          
Accounts receivable     (201,896) $ (200,922) (19,790)
Inventories     (6,568)   (70,847)
Other assets     (5,372)   18,125
Accounts payable     54,143   (17,205)
Deferred system revenue     (35,245)   (99,533)
Deferred service revenue     (3,117)   (1,114)
Other liabilities     107,131   20,381
Net cash provided by operating activities     883,976   663,577
Cash flows from investing activities:          
Business acquisitions, net of cash acquired     (78,530)   (11,787)
Capital expenditures     (67,440)   (48,696)
Proceeds from disposition of non-marketable securities     1,086   0
Purchases of available-for-sale securities     (408,482)   (2,686)
Proceeds from sale of available-for-sale securities     35,736   198,608
Proceeds from maturity of available-for-sale securities     357,450   382,809
Purchases of trading securities     (21,873)   (32,100)
Proceeds from sale of trading securities     27,212   37,334
Net cash (used in) provided by investing activities     (154,841)   523,482
Cash flows from financing activities:          
Proceeds from revolving credit facility     250,000   0
Repayment of debt     (275,000)   0
Common stock repurchases     (513,089)   (550,187)
Payment of dividends to stockholders     (256,332)   (237,319)
Issuance of common stock     24,613   20,556
Tax withholding payments related to vested and released restricted stock units     (35,775)   (30,194)
Payment of contingent consideration payable     (60)   0
Net cash used in financing activities     (805,643)   (797,144)
Effect of exchange rate changes on cash and cash equivalents     378   (315)
Net (decrease) increase in cash and cash equivalents     (76,130)   389,600
Cash and cash equivalents at beginning of period     1,015,994   1,404,382
Cash and cash equivalents at end of period $ 939,864 $ 1,793,982 939,864 $ 939,864 1,793,982
Supplemental cash flow disclosures:          
Income taxes paid     70,746   112,816
Interest paid     79,486   51,673
Non-cash activities:          
Business acquisition holdback amounts - investing activities     0   440
Contingent consideration payable - financing activities     5,825   2,529
Dividends payable - financing activities     3,190   5,404
Unsettled common stock repurchase - financing activities     4,000   0
Accrued purchases of land, property and equipment - investing activities     $ 13,755   $ 7,705